Skip to main content

Month: April 2022

Chalice Brands Ltd. Announces Execution of Definitive Agreements to Acquire Oregon Retail Stores and Cultivation Assets

PORTLAND, Ore., April 21, 2022 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (“Chalice” or the “Company”), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, is pleased to announce the signing of definitive agreements and services agreements (the “Agreements”) to acquire two retail stores located in Bend and Corvallis, Oregon from Miracle Greens, Inc (“Miracle Greens”) and two outdoor cultivation assets in Grants Pass, Oregon from Totem Farms, LLC (“Totem Farms”) for total consideration of US$2.63 million (“Purchase Price”). The closing of the transaction is subject to approval by the OLCC (“Oregon Liquor and Cannabis Commission”) and the satisfaction of other closing conditions. “We are very excited to be able to serve the Bend...

Continue reading

Consolidated Uranium Closes Acquisition of the Milo Uranium-Copper-Gold-REE and is Granted Gidyea Creek Project Tenements in Queensland, Australia

Figure 1 Gidyea Creek Project Location MapTORONTO, April 21, 2022 (GLOBE NEWSWIRE) — Consolidated Uranium Inc. (“CUR” or the “Company”) (TSXV: CUR) (OTCQB: CURUF) is pleased to announce that its has closed the previously announced acquisition (the “Acquisition”) of a 100% undivided interest in the Milo Uranium, Copper, Gold, Rare Earth Project (“Milo” or the “Project”) pursuant to the definitive sale and purchase agreement (the “Agreement”) dated November 10, 2021 between CUR and Isa Brightlands Pty Ltd (the “Vendor”), a wholly owned subsidiary of GBM Resources (“GBM”) (ASX: GBZ). The Project consists of Exploration Permit – Minerals (EPM) 14416, which includes 20 sub blocks or approximately 34 square kilometres located within The Mt Isa Inlier, approximately 40 kilometres west of Cloncurry in Northwestern Queensland, Australia. The...

Continue reading

Olink to report first quarter 2022 financial results on May 12, 2022

UPPSALA, Sweden, April 21, 2022 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the first quarter of 2022 before the market open on Thursday, May 12, 2022. Company management will host a conference call to discuss these results at 8:00 am ET. Investors interested in listening to the conference call may do so by dialing (833) 562-0120 for domestic callers or (661) 567-1096 for international callers, followed by Conference ID: 5650306. A live webcast of the conference call will be available on the “Investors” section of the Company’s website at https://investors.olink.com/investor-relations. The webcast will be archived and available for replay for at least 90 days after the event. About OlinkOlink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating...

Continue reading

Incap Group’s Business review for January-March 2022 and webcast 29 April 2022

Incap Corporation                  Press release                 21 April 2022 at 3:00 p.m. EESTIncap Group’s Business review for January-March 2022 will be published on Wednesday, 27 April 2022 at approximately 09:00 a.m. Finnish time. At that time, reporting materials in Finnish and English will be available on the company’s website at https://incapcorp.com/reports-and-presentations/. Webcast The company will hold a management webcast after Incap Corporation’s Annual General Meeting on Friday 29 April 2022 at 3:00 p.m. EEST. The result will be presented by Otto Pukk, CEO, and Antti Pynnönen, CFO, Incap Corporation. The live webcast can be followed at https://incap.videosync.fi/keskustelutilaisuus/. During the webcast, the public can ask questions in the chat room at the address mentioned above. The recording of the broadcast...

Continue reading

Aveanna Announces First Quarter 2022 Earnings Release Date and Conference Call

ATLANTA, April 21, 2022 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results after the market close on Wednesday, May 11, 2022, to be followed by a conference call on Thursday, May 12, 2022 at 10:00 a.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13728903. The replay will be available until May 19, 2022. Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations...

Continue reading

Mendix and Atos expand global partnership to drive efficient, digital decarbonization across every industry with enterprise low-code

Press Release Mendix and Atos expand global partnership to drive efficient, digital decarbonization across every industry with enterprise low-code      The partnership agreement between Atos and Mendix expands on the 10+ year strong relationship between Atos and Siemens It leverages low-code to accelerate hyper-automation, time-to-market, infrastructure modernization, and improve processes in manufacturing, retail, public sector, telecommunications and financial services The new partnership agreement enables Atos to drive low-code app development for digital transformation projects across the globeBoston, US, and Paris, France – April 21, 2022 – Mendix, a Siemens business and global leader in enterprise application development, and Atos, a global leader in digital transformation, today announced that they have signed an expanded partnership...

Continue reading

Program for the publication of Yara International ASA first quarter results 2022

The Yara International ASA first quarter 2022 results will be published on Wednesday 27 April 2022 at 08:00 CEST. An on-line presentation will be held at 12:00 CEST, hosted by Yara President and CEO Svein Tore Holsether. The presentation will be held in English. The report, presentation and webcast will be available at the above mentioned times at:yara.com/investor-relations/latest-quarterly-report/ There will also be a conference call at 13:00 CEST the same day with an opportunity to ask questions to Yara’s management. Please use this link for online registration for the conference call: http://emea.directeventreg.com/registration/4661876Participants must register in advance of the conference using the link provided. Upon registering, you will be provided with participant dial-in numbers, Direct Event passcode and unique registrant...

Continue reading

BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference

VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, today announced that an abstract on the preclinical data on anti-depressant activity of its lead compound 2-bromo-LSD (“BETR-001”) was accepted for presentation at the upcoming Canadian Association for Neuroscience (CAN) Conference, being held May 12-15 in Toronto, Canada. The study, led by Dr. Vern Lewis, is part of BetterLife’s collaboration with the laboratory of Dr. Argel Aguilar-Valles at Carleton University’s Department of Neuroscience. This collaboration is also supported by the Mitacs Accelerate program. At CAN, Dr. Lewis will present preclinical...

Continue reading

Olink to report first quarter 2022 financial results on May 12, 2022

UPPSALA, Sweden, April 21, 2022 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the first quarter of 2022 before the market open on Thursday, May 12, 2022. Company management will host a conference call to discuss these results at 8:00 am ET. Investors interested in listening to the conference call may do so by dialing (833) 562-0120 for domestic callers or (661) 567-1096 for international callers, followed by Conference ID: 5650306. A live webcast of the conference call will be available on the “Investors” section of the Company’s website at https://investors.olink.com/investor-relations. The webcast will be archived and available for replay for at least 90 days after the event. About OlinkOlink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating...

Continue reading

Todos Medical Appoints Philippe Goix as Chief Commercial Officer for Provista Diagnostics

Strengthens Management Team and Positions the Company for Growth and Expansion  New York, NY, and Tel Aviv, ISRAEL, April 21, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced the appointment of Philippe Goix as Chief Commercial Officer for Todos Medical’s wholly-owned CLIA/CAP certified lab, Provista Diagnostics. Dr. Goix brings more than 25 years of experience in the Life Sciences tools, Diagnostics and Health Information areas to Provista. Dr. Goix served as President & CEO of Prism Health Diagnostics, Inc. (PHDX), which he co-founded in late 2015 to establish ongoing wellness monitoring services as a business by delivering biomarker data to primary care, functional medicine physicians and consumers...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.